Market by Drug Class, Application, and Country | Forecast 2019-2028
According to Triton, the dermatological therapeutics market in Latin America is expected to proliferate with a CAGR of 7.26% in the forecast period of 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The countries
considered for evaluation in this market include:
• Brazil
• Mexico
• Rest of Latin America
In Mexico, the increase
in the burden of numerous dermatological conditions and the growth in the
awareness about various skin diseases are fueling the growth of the market for
dermatological therapeutics. As per data from the World Health Organization, 2,173
deaths were caused by skin diseases in Mexico in 2017. This has led to an
increase in the demand for dermatological treatments. Further, the growth in
the aging populace and age-related skin diseases have also enhanced the demand
for these services. In addition, there is a growing awareness about the
availability of the approved products in the country. All these factors are
fueling the dermatological therapeutics market growth in Mexico.
Ecuador, Bolivia,
Colombia, Chile, Peru, Venezuela, Uruguay, Paraguay, and others from the Rest
of Latin America region. As per the WHO data, 1,401 deaths were caused by skin
diseases in Colombia in 2017. This was followed by 399 deaths in Peru, 305
deaths in Chile, and 225 deaths in Bolivia. This has led to increased concern
among the population, and enhanced the demand for dermatological treatments.
Furthermore, 2019’s
World Population Aging report estimates the population aged 65 years or over in
Colombia to reach 6.962 million individuals in 2030, from 4.413 million
individuals in 2019. Similarly, this number is expected to increase to 3.338
million individuals in Chile by 2030, from 2.252 million in 2019. The geriatric
populace forms a large consumer base for dermatological therapeutic treatments.
All these factors are fueling the growth of the studied market in Rest of Latin
America.
Pfizer is a research-based globally renowned biopharmaceutical company. It is engaged in the development of consumer healthcare products, medicines, vaccines, and therapies for the treatment of various health conditions. EUCRISA is a prescription ointment provided by the company, which is used on the skin for the treatment of mild-to-moderate eczema. Pfizer has a notable presence in Latin America.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN
AMERICA DERMATOLOGICAL THERAPEUTICS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. KEY
INSIGHTS
2.2.1. ADVANCEMENTS
IN BIOLOGICS
2.2.2. ATOPIC
DERMATITIS IS ANTICIPATED TO GROW AT HIGHEST CAGR
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE
2.3.3. BARGAINING
POWER OF SUPPLIERS
2.3.4. BARGAINING
POWER OF BUYERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. IMPACT
OF COVID-19 – DERMATOLOGICAL THERAPEUTICS
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. MARKET
DRIVERS
2.7.1. INCREASING
BURDEN OF DERMATOLOGICAL DISEASES
2.8. MARKET
RESTRAINTS
2.8.1. GRAVE
SIDE-EFFECTS FOR CERTAIN CLASSES OF THERAPEUTIC DRUGS
2.9. MARKET
OPPORTUNITIES
2.9.1. RISE
IN AWARENESS LEVELS OF DISEASE ORIGIN AND PROGRESSION
2.10. MARKET
CHALLENGES
2.10.1. UNAWARENESS TOWARDS
DERMATOLOGICAL DIAGNOSIS
3. LATIN
AMERICA DERMATOLOGICAL THERAPEUTICS MARKET OUTLOOK – BY DRUG CLASS
3.1. ANTI-INFECTIVES
3.2. CORTICOSTEROIDS
3.3. ANTI-ACNE
3.4. CALCINEURIN
INHIBITORS
3.5. RETINOIDS
3.6. OTHER
DRUG CLASSES
4. LATIN
AMERICA DERMATOLOGICAL THERAPEUTICS MARKET OUTLOOK - BY APPLICATION
4.1. ALOPECIA
4.2. HERPES
4.3. PSORIASIS
4.4. ROSACEA
4.5. ATOPIC
DERMATITIS
4.6. ACNE
VULGARIS
4.7. OTHER
APPLICATIONS
5. LATIN
AMERICA DERMATOLOGICAL THERAPEUTICS MARKET – REGIONAL OUTLOOK
5.1. LATIN
AMERICA
5.1.1. COUNTRY
ANALYSIS
5.1.2. BRAZIL
5.1.3. MEXICO
5.1.4. REST
OF LATIN AMERICA
6. COMPETITIVE
LANDSCAPE
6.1. ABBVIE
INC
6.2. ALLERGAN
6.3. ALMIRALL
6.4. AMGEN
INC
6.5. BAUSCH
HEALTH COMPANIES INC
6.6. GALDERMA
6.7. GLAXOSMITHKLINE
PLC
6.8. JOHNSON
& JOHNSON
6.9. NOVARTIS
AG
6.10. PFIZER
INC
6.11. AGI
DERMATICS
6.12. LEO
PHARMA A/S
6.13. MERCK
& CO
7. METHODOLOGY
& SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.2. SOURCES
OF DATA
7.3. RESEARCH
METHODOLOGY
TABLE 1: LATIN AMERICA
DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)
TABLE 2: MARKET
ATTRACTIVENESS INDEX
TABLE 3: VENDOR SCORECARD
TABLE 4: LATIN AMERICA
DERMATOLOGICAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2028 (IN $ BILLION)
TABLE 5: LATIN AMERICA
DERMATOLOGICAL THERAPEUTICS MARKET, BY DRUG CLASS, 2019-2028 (IN $ BILLION)
TABLE 6: LATIN AMERICA
DERMATOLOGICAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2028 (IN $ BILLION)
FIGURE 1: PORTER’S FIVE
FORCES ANALYSIS
FIGURE 2: LATIN AMERICA
DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-INFECTIVES, 2019-2028 (IN $
BILLION)
FIGURE 3: LATIN AMERICA
DERMATOLOGICAL THERAPEUTICS MARKET, BY CORTICOSTEROIDS, 2019-2028 (IN $
BILLION)
FIGURE 4: LATIN AMERICA
DERMATOLOGICAL THERAPEUTICS MARKET, BY ANTI-ACNE, 2019-2028 (IN $ BILLION)
FIGURE 5: LATIN AMERICA
DERMATOLOGICAL THERAPEUTICS MARKET, BY CALCINEURIN INHIBITORS, 2019-2028 (IN $
BILLION)
FIGURE 6: LATIN AMERICA
DERMATOLOGICAL THERAPEUTICS MARKET, BY RETINOIDS, 2019-2028 (IN $ BILLION)
FIGURE 7: LATIN AMERICA
DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER DRUG CLASSES, 2019-2028 (IN $
BILLION)
FIGURE 8: LATIN AMERICA
DERMATOLOGICAL THERAPEUTICS MARKET, BY ALOPECIA, 2019-2028 (IN $ BILLION)
FIGURE 9: LATIN AMERICA
DERMATOLOGICAL THERAPEUTICS MARKET, BY HERPES, 2019-2028 (IN $ BILLION)
FIGURE 10: LATIN
AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY PSORIASIS, 2019-2028 (IN $
BILLION)
FIGURE 11: LATIN
AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ROSACEA, 2019-2028 (IN $
BILLION)
FIGURE 12: LATIN
AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ATOPIC DERMATITIS, 2019-2028 (IN
$ BILLION)
FIGURE 13: LATIN
AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY ACNE VULGARIS, 2019-2028 (IN $
BILLION)
FIGURE 14: LATIN
AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, BY OTHER APPLICATIONS, 2019-2028
(IN $ BILLION)
FIGURE 15: LATIN
AMERICA DERMATOLOGICAL THERAPEUTICS MARKET, REGIONAL OUTLOOK, 2019 & 2028
(IN %)
FIGURE 16: BRAZIL
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 17: MEXICO
DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)
FIGURE 18: REST OF
LATIN AMERICA DERMATOLOGICAL THERAPEUTICS MARKET 2019-2028 (IN $ BILLION)